Breaking: United States Business and Economy News

Breaking developments in the United States business and economy were officially reported, confirming multiple corporate acquisitions and regulatory actions. The following events state the business action directly and present the immediate, measurable outcome as disclosed by the involved entities.

Merck Acquired Cidara Therapeutics

Merck & Co. acquired Cidara Therapeutics Inc in a finalized transaction announced in early January 2026. The acquisition resulted in Cidara Therapeutics being removed from public trading and its drug development assets being transferred into Merck’s pharmaceutical portfolio.

Mars Acquired Kellanova

Mars Inc. completed the acquisition of Kellanova in a confirmed deal reported in December 2025. As a direct result, Kellanova ceased operating as an independent public company and its consumer food brands moved under Mars’ corporate ownership.

Merck Acquired Akero Therapeutics

Merck & Co. acquired Akero Therapeutics Inc through a completed transaction disclosed in December 2025. The acquisition resulted in Akero’s research programs and clinical assets being absorbed into Merck’s research and development operations.

U.S. SEC Proposed Regulatory Amendments

The United States Securities and Exchange Commission proposed amendments to small entity definitions for investment companies and investment advisers in January 2026. The action formally initiated a regulatory rulemaking process and opened the proposal to public comment.

City Office REIT Sold Equity Stake

City Office REIT Inc sold an equity stake to Morning Calm Management in a transaction recorded in January 2026. The result was an immediate change in the company’s ownership structure as disclosed in mandatory regulatory filings.